WIDAPLIK is the first and only FDA-approved triple combination medication for use as an initial therapy in patients likely to need multiple drugs to achieve blood pressure goals
AiMeD noted that proposed GST changes—to either 5% or 18%—both present significant risks requiring carefully nuanced consideration
The first pillar is advanced manufacturing, focused on upgrading existing CDMO
The company’s acquisition of a 51 per cent stake in Saarathi Healthcare earlier this financial year boosted growth
Medical plastics make up about 25 per cent of the 14,000 tons of waste generated daily in US healthcare facilities
The inspection concluded with NIL observations
Rivaroxaban is used to treat venous thromboembolism
Subscribe To Our Newsletter & Stay Updated